Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland

被引：0
|
作者：
Arjun Bhadhuri
Daniel Dröschel
Mike Guldimann
Claudia Jetschgo
Judit Banhazi
Matthias Schwenkglenks
C. Simone Sutherland
机构：
[1] Institute of Pharmaceutical Medicine (ECPM),
[2] University of Basel,undefined
[3] Novartis Pharma Schweiz AG,undefined
[4] Novartis Pharma AG,undefined
来源：
BMC Health Services Research | / 22卷
关键词：
RPE65; Cost effectiveness; Health Economics; Inherited retinal disease; Voretigene neparvovec; Switzerland;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Voretigene neparvovec in RPE65-related inherited retinal dystrophy: the 1-year real-world study LIGHT
    Audo, Isabelle
    Barale, Pierre-Olivier
    Devisme, Celine
    Mohand-Said, Saddek
    Meunier, Isabelle
    Smirnov, Vasily M.
    Dhaenens, Claire-Marie
    Andrieu, Camille
    Zeitz, Christina
    Pagot, Chloe
    Barbier, Pascaline
    Tindel, Malka
    Chapon, Perrine
    Sahel, Jose-Alain
    EYE, 2025,
  • [42] Frequency of RPE65 Gene Mutation in Patients with Hereditary Retinal Dystrophy
    Kahraman, Neslihan Sinim
    Oner, Ayse
    Ozkul, Yusuf
    Dundar, Munis
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2022, 52 (04): : 270 - 275
  • [43] Single center experience with Voretigene Neparvovec gene augmentation therapy in RPE65-mutation associated inherited retinal degeneration (vol 2, pg 161, 2024)
    Lorenz, Birgit
    Kunzel, Sandrine H.
    Preising, Markus N.
    Scholz, Johanna P.
    Chang, Petrus
    Holz, Frank G.
    Herrmann, Philipp
    OPHTHALMOLOGY, 2024, 131 (06) : 744 - 744
  • [44] EPIDEMIOLOGY OF RPE65 GENE MUTATION RELATED INHERITED RETINAL DYSTROPHIES: A SYSTEMATIC LITERATURE REVIEW
    Aouadj, C.
    Banhazi, J.
    Shaikh, J.
    Thakker, D.
    Lacey, S.
    Viriato, D.
    Fischer, M. D.
    VALUE IN HEALTH, 2018, 21 : S440 - S440
  • [45] Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy
    Lopez, Jennifer
    Borchert, Mark
    Lee, Thomas C.
    Nagiel, Aaron
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (03) : 299 - 301
  • [46] Long-term effect of voretigene neparvovec on the full-field light sensitivity threshold test of patients with RPE65 mutation-associated inherited retinal dystrophy: Post hoc analysis of Phase I trial data
    Chung, Daniel
    Reape, Kathleen
    High, Katherine A.
    Lacey, Sue
    Viriato, Daniel
    Grigg, John
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 968 - 968
  • [47] Long-term Effect of Voretigene Neparvovec on the Full-Field Light Sensitivity Threshold Test of Patients with RPE65 Mutation-Associated Inherited Retinal Dystrophy - Post Hoc Analysis of Phase I trial data
    Chung, Daniel C.
    Lee, Kelly
    Reape, Kathleen Z.
    High, Katherine A.
    Lacey, Sue
    Viriato, Daniel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [48] A morphometric analysis of the retinal arterioles with adaptive optics imaging in RPE65-associated retinal dystrophy after treatment with voretigene neparvovec
    Kortuem, Friederike C.
    Kempf, Melanie
    Merle, David A.
    Kuehlewein, Laura
    Pohl, Lisa
    Reith, Milda
    Jung, Ronja
    Ott, Saskia
    Stingl, Krunoslav
    Stingl, Katarina
    ACTA OPHTHALMOLOGICA, 2024, 102 (03) : e358 - e366
  • [49] Subretinal Deposits in Young Patients Treated with Voretigene Neparvovec-rzyl for RPE65-mediated Retinal Dystrophy
    不详
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [50] RPE65-associated retinal dystrophies: phenotypes and treatment effects with voretigene neparvovec (vol 241, pg 259, 2024)
    Stingl, Katarina
    Priglinger, Claudia
    Herrmann, Philipp
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (03) : e1 - e1
12345